GLP-1 Receptor Agonists Show Promise for Patients with Cancer and Type 2 Diabetes: JAMA Written By Jacinthlyn Sylvia13 Aug 2026 10:00 AM ISTA new study published in The Journal of Clinical Endocrinology and Metabolism show that patients with type 2 diabetes receiving treatment for active...
Hormonal Contraception Linked to Higher Semaglutide Use for Weight Control: JAMA Written By Dr Riya Dave7 Aug 2026 10:00 PM ISTA nested case-control study found that women of reproductive age using hormonal contraception were more likely to subsequently initiate semaglutide...
Weight loss drugs could help with binge eating disorder, suggests study Written By Dr. Kamal Kant Kohli17 July 2026 8:30 PM ISTDrugs commonly used for weight loss, known as GLP-1 receptor agonists, have been found to reduce the key symptoms of binge eating disorder, in a new...
GLP-1 Drugs Support-But Do Not Replace-Lifestyle Change, report patients in JAMA study Written By Dr Riya Dave2 July 2026 10:00 AM ISTResearchers have found in a new study that a qualitative study of patient experiences found that GLP-1 receptor agonists (GLP-1 RAs) act as a...
Experimental Pill Shows Promise for Type 2 Diabetes and Obesity: Study Written By Dr Kartikeya Kohli8 Jun 2026 8:15 PM ISTResearchers have found in a new study that a new experimental oral medication for type 2 diabetes and obesity may offer a novel treatment approach by...
GLP-1 Agonists Linked to Reduced Pain Medication Use and Fewer Pancreatic Procedures in Chronic Pancreatitis: Study Written By Medha Baranwal8 Jun 2026 8:00 PM ISTUK: A real-world study published in Gastro Hep Advances found that GLP-1 receptor agonists were associated with lower use of pain medications and...
GLP-1 Drugs Show Potential Benefits-and Risks in Eye Diseases, reports review Written By Dr Riya Dave25 May 2026 8:15 PM ISTA review published in BMC Ophthalmology has found that GLP-1 receptor agonists may help protect against ocular hypertension, glaucoma, late-stage...
Research Suggests Powerful Cancer Prevention Combo: GLP-1RAs and Progestins for Women at Risk Written By Dr Pooja N.22 May 2026 6:00 AM ISTNew Hope for Women Facing Endometrial Cancer RisksEndometrial cancer is now the most common gynecologic cancer in developed countries, with cases on...
Choosing Safer Diabetes Medications for Older Adults, suggests study Written By Dr. Kamal Kant Kohli1 May 2026 9:00 PM ISTOlder adults with type 2 diabetes face a difficult trade-off: they are among the most vulnerable to medication-related harms yet are often...
GLP-1 Therapy Linked to Lower Atrial Fibrillation and Mortality Risk-Independent of Weight Loss: Study Written By Dr. Kamal Kant Kohli25 April 2026 10:00 AM ISTUse of GLP-1 medications is associated with a reduced risk of atrial fibrillation and death, and this protective effect appears independent of weight...
GLP-1 Receptor Agonists Linked to Mild Erectile Dysfunction Risk: The Lancet Written By Dr Kartikeya Kohli23 April 2026 9:00 AM ISTUSA: Prior evidence on the association between GLP-1 receptor agonists and erectile dysfunction (ED) in men with type 2 diabetes has been...
No Ads for Prescription Drugs: Panel Flags Surrogate Advertising, Misleading Promotions of GLP-1 Obesity Drugs Written By Susmita Roy18 April 2026 8:51 PM ISTNew Delhi: The Drugs Consultative Committee (DCC), during its 68th meeting, deliberated on strengthening regulatory oversight and enforcement against...
